Itonis, Inc. Signs Marketing Agreement for 10,000 Commercial Spots for Anti-nausea Emesyl homeopathic product
Posted 10:30:00 05/18/2015 by Admin
LAGUNA HILLS, CA -- May 18, 2015 -- InvestorsHub NewsWire -- Itonis, Inc. (OTC PINKSHEETS: ITNS)
Itonis is pleased to announce that it has signed an agreement to provide marketing and public relations services for its Emesyl product, which will include Ten Thousand (10,000) thirty (30) second commercial spots.
The marketing agreement calls for placing the 10,000 commercial spots in select regional areas on the most popular cable television networks available. The networks available to Itonis for airing selection choice include ESPN, CNN, Fox News, Discovery Channel, SPIKE, AMC, TBS, Lifetime, A&E, Comedy Central, TV Land, Nickelodeon, Travel Channel, ESPN2, USA, HLN, BET, MTV, SyFy, CMT, TLC, TNT, and FX, etc., and have the ability to air more frequently in any of these select networks.
The agreement additionally provides Itonis, Inc. with National and International exposure via Internet distribution, and will also highlight and stream a live broadcast of company representatives on websites to be announced.
“This marketing effort is our next step to generate branding and retail sales for Emesyl. Studio production of the commercial should begin shortly, and we hope to provide a further update as that task progresses,” said Mark Cheung, CEO, Itonis, Inc. He further added, “This is a significant start into the television media that is separate from Hensley Brothers Distributions’ efforts in its distribution channels.”
About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis Inc. has focused on the distribution of innovative products to the medical and pharmaceutical industries. The company also holds a licensing agreement with MyECheck Inc, which allows the company to use MyECheck’s patented mobile payment application and share transaction revenue fees for point of purchase payments across various industries. Please visit www.itonisholdings.com for additional information.
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.
Stock Quote - ITNS
Investor RelationsItonis Holdings Company is a trade name of Itonis Inc. (OTC:ITNS), a publicly traded company.
Contact our office at (949) 200-8887 or email us at firstname.lastname@example.org for more information.
Latest Quarterly Reporthttp://www.otcmarkets.com/financialReportViewer?symbol=ITNS&id=153054